Showing results (21-30 of 203) with videos related to

Sort By:
Pageof 21
Expert Opinion on Pharmacotherapy|June 17, 2005
Proton pump inhibitors may reduce tumour resistanceAngelo De Milito, Stefano Fais
Expert Opinion on Therapeutic Patents|December 19, 2019
Drug repurposing for anticancer therapies. A lesson from proton pump inhibitorsEnrico Pierluigi Spugnini, Stefano Fais
Cancer Metastasis Reviews|November 8, 2014
Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapyStefano Fais, Giulietta Venturi, Bob Gatenby
Biomarkers in Medicine|September 19, 2013
Exosomes: the future of biomarkers in medicineFrancesca Properzi, Mariantonia Logozzi, Stefano Fais
Gastroenterology|May 10, 2008
Tetraspanin CD81-regulated cell motility plays a critical role in intrahepatic metastasis of hepatocellular carcinomaAntonio Mazzocca, Francesco Liotta, Vinicio Carloni
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 4, 2017
Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironmentPasquale Agosti, Carlo Sabbà, Antonio Mazzocca
Biochimica Et Biophysica Acta|March 4, 2010
Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link?Antonio Mazzocca, Gianluigi Giannelli, Salvatore Antonaci
Molecular Medicine (Cambridge, Mass.)|January 13, 2025
The systemic evolutionary theory of the origin of cancer (SETOC): an updateAntonio Mazzocca, Giovanni Ferraro, Giovanni Misciagna
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|December 16, 2022
Crithmum maritimum Improves Sorafenib Sensitivity by Decreasing Lactic Acid Fermentation and Inducing a Pro-Hepatocyte Marker Profile in Hepatocellular CarcinomaDavide Gnocchi, Carlo Sabbà, Antonio Mazzocca
Pageof 21